Hepion Pharmaceuticals Files 8-K
Ticker: CTRVP · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financial-reporting
TL;DR
Hepion Pharma filed an 8-K on 3/4/25. Standard update.
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on March 4, 2025, reporting on other events and financial statements. The company, formerly known as ContraVir Pharmaceuticals, Inc. until August 6, 2013, is incorporated in Delaware and headquartered in Edison, NJ.
Why It Matters
This filing provides an update on Hepion Pharmaceuticals' corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing that does not appear to contain significant new information or material changes.
Key Numbers
- 001-36856 — SEC File Number (Company's SEC filing identifier)
- 46-2783806 — IRS Identification No. (Company's tax identification number)
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
- March 4, 2025 (date) — Date of report
- August 6, 2013 (date) — Date of former name change
- Delaware (jurisdiction) — State of incorporation
- Edison, NJ (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves to report on 'Other Events' and 'Financial Statements and Exhibits' for Hepion Pharmaceuticals, Inc.
When was this report filed?
The report was filed on March 4, 2025.
What was Hepion Pharmaceuticals, Inc. previously named?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
On what date did the company change its name from ContraVir Pharmaceuticals, Inc.?
The date of the name change was August 6, 2013.
Where is Hepion Pharmaceuticals, Inc. headquartered?
The company's principal executive offices are located at 399 Thornall Street, First Floor, Edison, NJ 08837.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).